Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Stock Market Braces for Crucial Test Ahead of Data-Packed Week

Published 10/30/2023, 02:00 PM
Updated 09/20/2023, 06:34 PM

If you are taking a vacation this week, you chose the wrong week. From Tuesday until Friday, there will be a massive data dump. Starting Tuesday, we get the Employment Cost Index and Home Prices.

On Wednesday, we get ADP, JOLTS, ISM manufacturing, and the Fed. Thursday, Unit Labor costs, non-farm productivity, initial jobless claims, and durable goods.

On Friday, the jobs report and the ISM services.

This is the type of data that is not going only to move the markets but also set the tone and the dialogue for fourth-quarter GDP growth.

This means the US dollar and rates will be more volatile, and the equity market will be trading off dollar and rate changes.

US Dollar Poised to Go Higher?

The dollar looks like it wants to go higher from here based on what appears to be a bull flag that has formed. That pattern in the dollar could be setting up for a considerable move higher back towards 109.50 on the dollar index.

The data that comes this week will need to support that narrative, and the Fed messaging will, too. However, based on how the dollar appears to be setting up heading into this week, it seems the dollar may get the hot data and hawkish Fed.US Dollar Index-Daily Chart

Euro in Bear Flag: What Awaits?

Similar patterns are present in the euro with what appears to be a bear flag, which makes sense given the euro’s weighting in the dollar index. This bearish pattern in the euro suggests a drop back to around 1.03.EUR/USD-Daily Chart

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

10-Year Consolidating Around the 5% Level

Meanwhile, we are seeing the 10-year also consolidate around the 5% level and appear to be forming a bull flag, too, which is suggestive of a 10-year rate that is also likely to move higher and see a move perhaps to that 5.25% level.10-Yr Yield-Daily Chart

It isn’t that we are only seeing higher rates, but we are finally witnessing spreads widen as investors reassess the rates they are getting paid for the amount of risk they are taking.

This is happening not just in the US but in Europe, too, with German and Italian sovereign spreads widening, which has resulted in high-yield spreads here in the US widening, too.

German-Italian 10-Yr Spread Chart

Widening spreads in the US have led to rising levels of implied volatility for the equity market and higher earning yields, which have led to lower equity prices.

What is pushing equities lower is not only higher rates but the repricing of risk due to those higher rates.

The market seemed to think that rates would stay low, and because, in the market’s view, rates would remain low, there was no reason to reprice risk. But that has all changed. Spreads Volume

So, as long as rates and the dollar continue to climb, the repricing of risk shall likely continue because it doesn’t seem that, at the current level, stocks are correctly priced given bond yields.

The SPY to IEF ratio shows that stocks will likely underperform relative to bonds over the short term.SPY/IEF Ratio-Daily Chart

Biotech Sector May Continue Lower

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

For the biotech ETF (XBI) has fallen back to levels seen in 2017, 2018, 2020, and 2022. The sad thing for this group is that it may not be finished falling, either.

If the XBI should break support around $64, the next level of support comes at gap fills from 2016 at $54 and $57.XBI-Daily Chart

Russell 2000 (IWM) Back to Its 2022 Lows

When biotech underperforms, small-cap underperforms, which has the (IWM) back to its 2022 lows.

You can see how ominous the triple top in the IWM looks and what a break of the neckline at $162.50 could mean for the IWM, with gaps to fill down around $127. Russell 2000 ETF-Daily Chart

ARKK Innovation ETF Trades Near 2017 Low

This is more broadly a sign of long-duration growth assets doing poorly, which is also why the ARKK ETF is trading back near its low and a level seen back in 2017.ARK-Daily Chart

Magnificent 7 Stocks Start to Price in High Rates

This is probably why the Mag 7, when added into one entity, has the same look as the SPY to IEF and the QQQ to IEF ratio. They are telling us the same thing.

Stocks are repricing for a higher rate world, and the higher rates go, the more stocks will need to reprice.

So, if you are trying to understand when stocks will stop falling, turn your attention to the macro data, bonds, and the dollar. They will tell you when stocks have finished falling before stocks will tell you when they are finished falling.Mag7 Stocks-Daily Chart

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

THIS WEEK'S FREE YOUTUBE VIDEO:

Original Post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.